Lataa...
Controversies about extended-spectrum and AmpC beta-lactamases.
Many clinical laboratories have problems detecting extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamases. Confusion exists about the importance of these resistance mechanisms, optimal test methods, and appropriate reporting conventions. Failure to detect these enzymes h...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Centers for Disease Control and Prevention
2001
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2631719/ https://ncbi.nlm.nih.gov/pubmed/11294735 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|